Literature DB >> 15580464

[Gamma-hydroxybutyrate--a neurotransmitter, medicine, and drug].

G Trendelenburg1, A Ströhle.   

Abstract

Gamma-hydroxybutyrate (GHB) is a short fatty acid and physiologic neurotransmitter. Initially, it was synthesized as a GABA agonist and used as a narcotic agent, because it rapidly induces sleep without major cardiovascular or respiratory side effects. Recently, a specific GHB receptor was identified, but while the clinical use of GHB as an anaesthetic was reduced due to putative pro-convulsive effects, it now is used to treat alcohol withdrawal and sleep disorders. Furthermore, GHB was postulated to be a regulator of energy metabolism, and tissue-protective effects were demonstrated in different animal models. Besides its clinical use, GHB (also called "liquid ecstasy") is increasingly consumed in the disco scene because of its mild sedative and euphoric effects. Intoxication from GHB is common with GHB users. For this reason and because GHB is not easy to detect, it is important to be aware of the symptoms of GHB intoxication. Moreover, some recent case reports document the danger of GHB dependence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580464     DOI: 10.1007/s00115-004-1852-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  27 in total

1.  Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

Authors:  A R Winstock; P Griffiths; D Stewart
Journal:  Drug Alcohol Depend       Date:  2001-09-01       Impact factor: 4.492

2.  Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?

Authors:  R Bernasconi; P Mathivet; S Bischoff; C Marescaux
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

3.  Gamma-hydroxybutyrate dependence with social phobia.

Authors:  George Trendelenburg; Andreas Heinz; Andreas Ströhle
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

4.  Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.

Authors:  G Addolorato; M Cibin; E Capristo; F Beghe; G Gessa; G F Stefanini; G Gasbarrini; E Caprista
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

5.  Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain.

Authors:  Serge Gobaille; Carmen Schleef; Viviane Hechler; Sandrine Viry; Dominique Aunis; Michel Maitre
Journal:  Life Sci       Date:  2002-03-22       Impact factor: 5.037

Review 6.  GHB: a new and novel drug of abuse.

Authors:  K L Nicholson; R L Balster
Journal:  Drug Alcohol Depend       Date:  2001-06-01       Impact factor: 4.492

7.  Gamma hydroxy butyrate use--New York and Texas, 1995-1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-04-04       Impact factor: 17.586

8.  Clinical course of gamma-hydroxybutyrate overdose.

Authors:  R L Chin; K A Sporer; B Cullison; J E Dyer; T D Wu
Journal:  Ann Emerg Med       Date:  1998-06       Impact factor: 5.721

Review 9.  From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid.

Authors:  C Guin Ting Wong; K Michael Gibson; O Carter Snead
Journal:  Trends Pharmacol Sci       Date:  2004-01       Impact factor: 14.819

Review 10.  Sites of action of gamma-hydroxybutyrate (GHB)--a neuroactive drug with abuse potential.

Authors:  G Tunnicliff
Journal:  J Toxicol Clin Toxicol       Date:  1997
View more
  3 in total

1.  [Severe delirium in withdrawal from chronic gamma-hydroxybutyric acid consumption].

Authors:  G Proest; T Zschernack; M Stelzig; B Steinacher
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

2.  [Agitation and gamma-hydroxybutyrate].

Authors:  M Hardmeier; M Eichhorn; G Stoppe
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

3.  Poisoning cases in the German crime series Tatort (crime scene) from 1974 to 2022.

Authors:  Rachel Ellerbeck; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-08-16       Impact factor: 3.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.